Characteristics and outcomes among lung transplant patients with respiratory syncytial virus infection
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characteristics and outcomes among lung transplant patients with respiratory syncytial virus infection
Authors
Keywords
-
Journal
Transplant Infectious Disease
Volume 23, Issue 4, Pages -
Publisher
Wiley
Online
2021-06-23
DOI
10.1111/tid.13661
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT
- (2019) Geert M. Verleden et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Oral and Inhaled Ribavirin Treatment for Respiratory Syncytial Virus Infection in Lung Transplant Recipients
- (2019) Nitipong Permpalung et al. TRANSPLANTATION
- Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem
- (2017) Ralph A. Tripp et al. JOURNAL OF VIROLOGY
- ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients
- (2016) Jens Gottlieb et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative
- (2016) O.E. Beaird et al. Transplant Infectious Disease
- Graft Loss and CLAD-Onset Is Hastened by Viral Pneumonia After Lung Transplantation
- (2016) Paul R. Allyn et al. TRANSPLANTATION
- Symptomatic Respiratory Virus Infection and Chronic Lung Allograft Dysfunction
- (2015) Cynthia E. Fisher et al. CLINICAL INFECTIOUS DISEASES
- Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency
- (2015) Fay S. Burrows et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation
- (2015) Kari Neemann et al. Current Infectious Disease Reports
- Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation
- (2012) Lily Li et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Respiratory Viruses in Lung Transplant Recipients: A Critical Review and Pooled Analysis of Clinical Studies
- (2011) D.-L. Vu et al. AMERICAN JOURNAL OF TRANSPLANTATION
- CXCR3 Chemokine Ligands During Respiratory Viral Infections Predict Lung Allograft Dysfunction
- (2011) S. S. Weigt et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Respiratory Viral Infections in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
- (2011) S. Weigt et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus
- (2010) Martin R. Zamora et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Viral Infections in Lung Transplant Recipients
- (2010) Pali Shah et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients
- (2009) V. Liu et al. Transplant Infectious Disease
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started